Laura J. Else

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

Journal: The Journal of antimicrobial chemotherapy
Published: November 19, 2025

Pre-exposure prophylaxis use in blood donors in England.

Pre-exposure prophylaxis use in blood donors in England.

Journal: Vox sanguinis
Published: October 22, 2025

PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing.

PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing.

Journal: Clinical pharmacology and therapeutics
Published: October 15, 2025

Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers.

Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers.

Journal: PloS one
Published: October 12, 2025

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Journal: Clinical pharmacology and therapeutics
Published: October 08, 2025

A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens.

A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens.

Journal: The Journal of antimicrobial chemotherapy
Published: July 01, 2025

The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis.

The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis.

Journal: The Journal of antimicrobial chemotherapy
Published: March 20, 2025

Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study.

Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study.

Journal: Antiviral research
Published: June 05, 2024

Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.

Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults.

Journal: EBioMedicine
Published: May 16, 2024

Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.

Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.

Journal: Frontiers in immunology
Published: April 10, 2024

A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells.

A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells.

Journal: Journal of pharmaceutical and biomedical analysis
Published: February 02, 2024

Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.

Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.

Journal: The Journal of antimicrobial chemotherapy
Published: January 19, 2024
Showing 1-12 of 99

Last Updated: 09/26/2026